EVH
Evolent Health, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$4.30
+0.82%Year over year
Reported trailing growth
- Revenue
- -4.5%
- EBITDA
- —
- EBIT
- +14.8%
- EPS
- —
- Free cash flow
- +126.8%
- Operating cash flow
- +260.0%
Forward estimates
Based on analyst estimates
- Revenue
- +49.1%
- EBITDA
- +164.0%
- EPS
- +107.5%
Three-year CAGR
- Revenue
- +11.5%
- EBITDA
- —
- EBIT
- +89.0%
- Net income
- —
- EPS
- —
- Free cash flow
- -79.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026